Atezolizumab, Guadecitabine, and CDX-1401 Vaccine in Treating Patients With Recurrent Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Stemline Therapeutics, Inc.
Augusta University
Roswell Park Cancer Institute
Ludwig Institute for Cancer Research
Icahn School of Medicine at Mount Sinai
Celldex Therapeutics
University Hospital, Geneva